News for 'Institute of Development Studies'

Little Trust makes big impact in assessing TN's child development problem

Little Trust makes big impact in assessing TN's child development problem

Rediff.com18 Dec 2013

A Ganesh Nadar profiles a non-governmental organisation that has revealed startling figures about the state's poor children.

Is Tourism Destroying Goa?

Is Tourism Destroying Goa?

Rediff.com24 Feb 2023

Poor governance and mediocre short-sighted politics are destroying the paradise that Goa was as its environment, water table, culture and way of life is drastically threatened by tourism and migration, points out Ramesh Menon.

3 COVID vaccines under active consideration: Health ministry

3 COVID vaccines under active consideration: Health ministry

Rediff.com8 Dec 2020

Over the last four days, the Indian arm of US pharmaceutical giant Pfizer, Pune-based Serum Institute of India and Hyderabad-based pharmaceutical firm Bharat Biotech have applied to the Drugs Controller General of India seeking emergency use authorisation for their COVID-19 vaccines.

CAT Tips: 'Spend at least 3 hours a day to study'

CAT Tips: 'Spend at least 3 hours a day to study'

Rediff.com2 Oct 2014

Manish Kumar who achieved a high percentile of 99.43 in CAT 2013 and secured admission in IIM Raipur tells us how he succeeded in cracking the test.

Sri Lanka: 'Political stability must be restored'

Sri Lanka: 'Political stability must be restored'

Rediff.com7 May 2022

'For the common man, the economic conditions are not going to get better.'

Rushali's Advice For Aspiring Models

Rushali's Advice For Aspiring Models

Rediff.com20 Oct 2022

Ajmer-born model and entrepreneur Rushali Yadav talks about her fashion journey.

2 antibodies that can neutralise coronavirus identified

2 antibodies that can neutralise coronavirus identified

Rediff.com13 Jul 2020

The study, published in the journal Nature Structural & Molecular Biology, noted that the 'nanobodies' can prevent infection with the novel coronavirus SARS-CoV-2 by blocking its interaction with the protein ACE2, which it uses as a gateway to enter and infect cells.

Study New Zealand: What you MUST know

Study New Zealand: What you MUST know

Rediff.com7 May 2008

Excerpts of an exclusive interview with Ms Kerry Greig, Immigration Manager with New Zealand High Commission and Mr. Maninder Singh, Expert, Admission services with BetterThink, a language division of Top Careers & You (TCY) on what you must know before going to NZ for higher studies.

Cow is mother, sacred to us, says Modi in Varanasi

Cow is mother, sacred to us, says Modi in Varanasi

Rediff.com23 Dec 2021

He said those making jokes on cows and buffaloes forget that the livelihood of crores of people depends on "pashudhan".

Phase 3 clinical trial of Oxford vaccine begins in Pune

Phase 3 clinical trial of Oxford vaccine begins in Pune

Rediff.com21 Sep 2020

"We have started the phase-III trials of the vaccine (candidate Covishield). We will administer dose to 150 to 200 volunteers," said Dr Muralidhar Tambe, Dean, Sassoon General Hospital.

Lessons from Uttarakhand: When 'development' is destruction

Lessons from Uttarakhand: When 'development' is destruction

Rediff.com28 Jun 2013

To avert another Uttarakhand-type catastrophe, we must change course. We should stop pandering to the Indian elite's insatiable appetite for electricity, which is driving reckless dam construction, says Praful Bidwai

Rahul's assets rose from Rs 9.4 cr to 15.88 cr in 5 years

Rahul's assets rose from Rs 9.4 cr to 15.88 cr in 5 years

Rediff.com5 Apr 2019

Gandhi has declared that his source of income was MP's salary, royalty income, rental income, interest from bonds, dividends and capital gain from mutual funds.

Discrimination at IIT-Madras? 'It's subtle, you can feel it'

Discrimination at IIT-Madras? 'It's subtle, you can feel it'

Rediff.com20 Nov 2019

In the wake of Fathima Lateef's tragic suicide at IIT-Madras, A Ganesh Nadar/Rediff.com speaks to students and professors to find out if one of India's leading educational institutions has a dark side to it.

10 HOT careers for IT grads

10 HOT careers for IT grads

Rediff.com15 Apr 2021

Engineering graduates specialising in artificial intelligence and machine learning can earn up to 24 lakh a year, says Saran Balasundaram, founder and CEO, HanDigital, a talent consulting firm.

'Climate change has increased the number and intensity of cyclones in the Arabian Sea'

'Climate change has increased the number and intensity of cyclones in the Arabian Sea'

Rediff.com23 Mar 2022

'The food security along the coastal region will be severely affected.'

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Bharat Biotech asked to submit phase 2 data of its Covid vaccine

Rediff.com10 Oct 2020

The vaccine candidate -- 'Covaxin' -- is being indigenously developed by the Bharat Biotech in collaboration with the Indian Council of Medical Research (ICMR).

Focus on double vaccination first: Experts amid calls for booster

Focus on double vaccination first: Experts amid calls for booster

Rediff.com4 Dec 2021

'Scientific data has proven that masks can reduce COVID-91 transmission by 53 per cent...A booster dose of vaccine, even if it works, is just a temporary fix'

India-US coalition begin clinical trials for coronavirus

India-US coalition begin clinical trials for coronavirus

Rediff.com17 Mar 2020

The trial began at the Kaiser Permanente Washington Health Research Institute in Seattle as the first participant received the investigational vaccine.

India's vaccine makers prepare to take on Omicron

India's vaccine makers prepare to take on Omicron

Rediff.com8 Dec 2021

As the Omicron variant of Sars-CoV-2 takes centrestage, vaccine makers in India are of the view that scaling up the existing vaccines to make them more effective is possible.

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Covaxin gets nod for phase 2, 3 clinical trials on 2-18 year-olds

Rediff.com12 May 2021

The trial will take place in 525 subjects at various sites, including AIIMS, Delhi, AIIMS, Patna and Meditrina Institute of Medical Sciences, Nagpur.

HC says depression a serious illness during Covid, upholds student's plea

HC says depression a serious illness during Covid, upholds student's plea

Rediff.com2 Sep 2021

Depression can be classified as a serious illness, especially in the context of the Covid-19 pandemic, the Gujarat high court has observed, while setting aside the cancellation of registration and admission of an engineering student by a government college for not appearing for requisite exams due to depression and suicidal thoughts.

Entry-level jobs no more easy to come by in formal sector

Entry-level jobs no more easy to come by in formal sector

Rediff.com11 Jul 2022

It is a trend that economists and researchers say might continue. The data shows the share of this age group in the net EPF accounts created - a proxy for net new formal jobs created - fell from 37.9 per cent in 2018-19 to 24.1 per cent in 2021-22.

India working on Russia's proposal to manufacture Covid vaccine

India working on Russia's proposal to manufacture Covid vaccine

Rediff.com8 Sep 2020

Dr V K Paul, Member (Health) Niti Aayog, who also chairs the national expert group on COVID-19 vaccine administration, said the government attaches 'great importance to this offer of partnership from a very special friend to this nation'.

Oxford varsity enrols volunteers for Covid vaccine trial

Oxford varsity enrols volunteers for Covid vaccine trial

Rediff.com28 Mar 2020

The researchers, working in an 'unprecedented' vaccine development effort to prevent COVID-19, said they have started screening healthy volunteers (aged 18-55) from Friday for their upcoming trial in the Thames Valley Region of England.

Musk, The Blue Tick, Twitter's Future

Musk, The Blue Tick, Twitter's Future

Rediff.com18 Nov 2022

It would be ludicrous to expect Modi, Erdogan or Biden to pay to keep blue ticks on their respective official accounts. It would be equally ludicrous to expect the Delhi Metro or the Income Tax Department to pay, points out Devangshu Datta.

Air pollution reducing life expectancy in India by 5 years

Air pollution reducing life expectancy in India by 5 years

Rediff.com14 Jun 2022

The residents of Delhi stand to lose 10 years of life expectancy if the current air pollution level persists.

'Cyber attackers are 10 steps ahead'

'Cyber attackers are 10 steps ahead'

Rediff.com4 Apr 2023

'Hacking of an ID or an account will have the same impact on a user in a city and one in a small town.' 'Security is like a railroad, you create it to last for every customer.'

Make Your Network Your Net Worth

Make Your Network Your Net Worth

Rediff.com15 Nov 2022

'Who you know today will determine who you know tomorrow.' 'Becoming an expert in your domain will incentivise others to have you in their networks.' 'And the more diverse your network, the better it is.' An enlightening excerpt from Ambi Parmeswaran's All The World's A Stage: A Personal Branding Story.

'Coronavirus strain predominant in India originated in Europe'

'Coronavirus strain predominant in India originated in Europe'

Rediff.com3 Sep 2020

'Given that the globally most prevalent clade of SARS-CoV-2 is also predominant in India, any vaccine or drug that gets developed in the world should also prove effective in India'

Who shouldn't take jab? Vaccine makers issue fact sheet

Who shouldn't take jab? Vaccine makers issue fact sheet

Rediff.com19 Jan 2021

The fact sheet also asked people to inform the vaccinator or a supervising official about their medical condition before taking the vaccine.

Bharat Biotech has two more Covid vaccines in pipeline

Bharat Biotech has two more Covid vaccines in pipeline

Rediff.com16 Jan 2021

First a scientist and then a businessman, founder chairman Krishna Ella quit his faculty position at the Medical University of South Carolina in Charleston, United States, in 1996 to return to India.

Biden picks Kashmiri-origin Sameera Fazili in WH team

Biden picks Kashmiri-origin Sameera Fazili in WH team

Rediff.com16 Jan 2021

In December, Aisha Shah was named as Partnerships Manager at the White House Office of Digital Strategy.

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Dr Reddy's soft-launches Sputnik V in India at Rs 995 per dose

Rediff.com15 May 2021

Dr Reddy's Laboratories on Friday soft-launched imported COVID-19 vaccine Sputnik V, with Deepak Sapra, a senior executive of the drug-maker, taking the first shot in Hyderabad.

Oxford COVID-19 vaccine promising, but...: Scientists

Oxford COVID-19 vaccine promising, but...: Scientists

Rediff.com21 Jul 2020

Doses of the vaccine were given to 1,077 healthy adults aged between 18 and 55 in five United Kingdom hospitals in April and May as part of the phase one clinical trial.

Hijab row: K'taka schools reopen on Monday, CM confident of peace

Hijab row: K'taka schools reopen on Monday, CM confident of peace

Rediff.com13 Feb 2022

He also said that a decision regarding reopening of pre-university and degree colleges will be taken after assessing the situation.

This path-breaking vaccine may win a Nobel, and it's for not Covid

This path-breaking vaccine may win a Nobel, and it's for not Covid

Rediff.com20 Oct 2021

The new malaria vaccine (RTS.S/ AS01, tentatively brand-named Mosquirix) is the very first one to offer immunity against a parasite -- specifically the plasmodium falciparum parasite, which is the deadliest of the five parasites that cause malaria.

Chanakya's TIPS to be a WINNER

Chanakya's TIPS to be a WINNER

Rediff.com7 Jan 2022

It is said in Chanakya Neeti that the grass on the ground survives the storm because it is flexible as per the direction of the wind. The large trees break down easily as they are strong and rigid. Winners are not rigid, they are flexible. At the same time, they are focused on winning. A must read excerpt from Radhakrishnan Pillai's Art Of Winning: The Chanakya Way.

Govt panel recommends regular market approval for Covishield, Covaxin

Govt panel recommends regular market approval for Covishield, Covaxin

Rediff.com20 Jan 2022

An expert panel of India's central drug authority on Wednesday recommended granting regular market approval to COVID vaccines Covishield and Covaxin for use in adult population subject to certain conditions, official sources said.

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

PM reviews preparations for vaccination against COVID-19

PM reviews preparations for vaccination against COVID-19

Rediff.com30 Jun 2020

The PM directed officials to evaluate various technology tools to ensure efficient and timely vaccination in due course of time. He also emphasised that detailed planning for such large scale vaccination should be undertaken immediately.